Abstract
The excellent survival rate with cardiac transplantation now makes this a potentially attractive procedure in many patients who have debilitating congestive heart failure despite optimal medical therapy. Because the number of donor hearts is severely limited, there are many patients on transplant waiting lists and the waiting time can be more than several months. As a consequence, many patients die while awaiting transplantation. Alternatively, it has been observed that some patients who survive several months on a waiting list may derive relatively little incremental advantage from the procedure. We review the process of selecting patients for cardiac transplantation, including consideration of the major indications, exclusionary factors, and how best to select patients who have the greatest potential for benefit. (Cardiol Rev 1993;1:4, 218-227)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
